Fatal disseminated mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report Surg Case Rep.,8(1):164 2022 Author:Mita A, Hirano S, Uehara T, Uehara K, Ohno Y, Kubota K, Masuda Y, Notake T, Yoshizawa K, Shimizu A, Soejima Y.
Small-for-size syndrome in liver transplantation: Definition, pathophysiology and management Hepatobiliary Pancreat Disease International 2020(Jun. 30) Author:Yuichi Masuda, Kazuki Yoshizawa, Yasunari Ohno, Atsuyoshi Mita, Akira Shimizu, Yuji Soejima
Segmental Hepatic Steatosis Due to Portal Vein Stricture After Pediatric Living Donor Liver Transplantation: A Case Report. Transplant Proc.,52(6):1944-1949 2020(May) Author:Mita A, Kurozumi M, Ohno Y, Masuda Y, Yoshizawa K, Nakazawa Y, Kobayashi A, Ikegami T, Soejima Y.
Interferon-free Anti-hepatitis C Virus Treatment for Long-term Liver Transplantation Recipients with Failed Interferon Therapy Shinshu Medical Journal,67(6):417-423 2019(Dec. 10) Author:Kiyotaka HOSODA, Yuichi MASUDA, Atsuyoshi MITA, Akira KOBAYASHI
The Effect of Nrf2 Pathway Activation on Human Pancreatic Islet Cells. PLoS One.,10(6):e0131012 2015(Jun. 25) Author:Masuda Y, Vaziri ND, Li S, Le A, Hajighasemi-Ossareh M, Robles L, Foster CE1, Stamos MJ1, Al-Abodullah I3, Ricordi C, Ichii H
Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver. Gastroenterol Hepatol (Que),1(1):1-7 2014(Aug. 26) Author:Masuda Y, Vaziri ND, Takasu C, Li S, Robles L, Pham C, Le A, Vo K, Farzaneh SH, Stamos MJ, Ichii H.
At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death. Am J Transl Res,6:64-70 2013(Dec. 01) Author:Masuda Y, Ichii H, Vaziri ND.
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. Am J Nephrol.,36:50-7 2012(Jun. 19) Author:Ichii H, Masuda Y, Hassanzadeh T, Saffarian M, Gollapudi S, Vaziri ND.
Clinicopathological features of hepatitis C virus disease after living donor liver transplantation: relationship with in situ hybridisation data. Pathology,43:156-160 2011 Author:Masuda Y, Nakazawa Y, Matsuda K, Sano K, Mita A, Ohno Y, Urata K, Ikegami T, Miwa S, Miyagawa S.
Noncompliance with Medications in Pediatric Patients after Living-Donor Liver Transplantation. Transplantation Proceedings,42:4191-4192 2010 Author:Masuda Y, Mita A, Ohno Y, Urata K, Nakazawa Y, Ikegami T, Terada M, Miyagawa S.
講演・口頭発表等 Liver Retransplantation Long-Term After Living Donor Liver Transplantation: A Single-Center Experience. 2014 World Transplant Congress 2014(Jul. 27) Presenter:Y. Masuda, T. Ikegami, Y. Ohno, A. Mita, K. Urata, Y. Nakazawa, A. Kobayashi, S. Miyagawa.
The effect of Nrf2-keap1 pathway activation on human pancreatic β cells American Transplant Congress 2013 2014(May 20) Presenter:Yuichi Masuda, Shiri Li, Aimee Le, Mohammad Hajighasemi-Ossareh, Clarence E Foster, Nosratola D Vaziri, and Hirohito Ichii